Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pizza

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 28, 1995
Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvantsG Douce, C Turcotte, I Cropley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 1999
MHC class I-restricted cytotoxic lymphocyte responses induced by enterotoxin-based mucosal adjuvantsC P Simmons, P Mastroeni, R Fowler, et al.
Biomolecular NMR Assignments|December 29, 2010
1H, 13C and 15N assignment of the GNA1946 outer membrane lipoprotein from Neisseria meningitidisA Neumoin, A Leonchiks, P Petit, et al.
Infection and Immunity|March 1, 1996
Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvantA Di Tommaso, G Saletti, M Pizza, et al.
Infection and Immunity|November 24, 1999
Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cellsE J Ryan, E McNeela, G A Murphy, et al.
Infection and Immunity|October 1, 1996
Expression and immunogenicity of pertussis toxin S1 subunit-tetanus toxin fragment C fusions in Salmonella typhi vaccine strain CVD 908E M Barry, O Gomez-Duarte, S Chatfield, et al.
Infection and Immunity|June 1, 1995
Construction of nontoxic derivatives of cholera toxin and characterization of the immunological response against the A subunitM R Fontana, R Manetti, V Giannelli, et al.
Infection and Immunity|October 15, 2008
Factor H-binding protein is important for meningococcal survival in human whole blood and serum and in the presence of the antimicrobial peptide LL-37K L Seib, D Serruto, F Oriente, et al.
Infection and Immunity|June 1, 1995
A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K/129G, is an effective mucosal adjuvant for intranasally delivered proteinsM Roberts, A Bacon, R Rappuoli, et al.
Infection and Immunity|May 1, 1990
Characterization of genetically inactivated pertussis toxin mutants: candidates for a new vaccine against whooping coughL Nencioni, M Pizza, M Bugnoli, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Proceedings of the National Academy of Sciences of the United States of America|February 28, 1995
Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvantsG Douce, C Turcotte, I Cropley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 1999
MHC class I-restricted cytotoxic lymphocyte responses induced by enterotoxin-based mucosal adjuvantsC P Simmons, P Mastroeni, R Fowler, et al.
Biomolecular NMR Assignments|December 29, 2010
1H, 13C and 15N assignment of the GNA1946 outer membrane lipoprotein from Neisseria meningitidisA Neumoin, A Leonchiks, P Petit, et al.
Infection and Immunity|March 1, 1996
Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvantA Di Tommaso, G Saletti, M Pizza, et al.
Infection and Immunity|November 24, 1999
Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cellsE J Ryan, E McNeela, G A Murphy, et al.
Infection and Immunity|October 1, 1996
Expression and immunogenicity of pertussis toxin S1 subunit-tetanus toxin fragment C fusions in Salmonella typhi vaccine strain CVD 908E M Barry, O Gomez-Duarte, S Chatfield, et al.
Infection and Immunity|June 1, 1995
Construction of nontoxic derivatives of cholera toxin and characterization of the immunological response against the A subunitM R Fontana, R Manetti, V Giannelli, et al.
Infection and Immunity|October 15, 2008
Factor H-binding protein is important for meningococcal survival in human whole blood and serum and in the presence of the antimicrobial peptide LL-37K L Seib, D Serruto, F Oriente, et al.
Infection and Immunity|June 1, 1995
A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K/129G, is an effective mucosal adjuvant for intranasally delivered proteinsM Roberts, A Bacon, R Rappuoli, et al.
Infection and Immunity|May 1, 1990
Characterization of genetically inactivated pertussis toxin mutants: candidates for a new vaccine against whooping coughL Nencioni, M Pizza, M Bugnoli, et al.
Pageof 8